BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23382561)

  • 21. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental ages of the thymic epithelium and of the T cell precursors together determine the proportions of peripheral CD4+ cells.
    Adkins B; Hamilton K
    J Immunol; 1994 Dec; 153(12):5359-65. PubMed ID: 7989742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.
    Nishida T; Hosaka N; Takaki T; Miyake T; Cui W; Inaba M; Kinoshita H; Matsuda T; Ikehara S
    Bone Marrow Transplant; 2009 Jun; 43(11):829-37. PubMed ID: 19079314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism.
    Mapara MY; Kim YM; Marx J; Sykes M
    Transplantation; 2003 Jul; 76(2):297-305. PubMed ID: 12883182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.
    Spitzer TR; McAfee S; Sackstein R; Colby C; Toh HC; Multani P; Saidman S; Weyouth DW; Preffer F; Poliquin C; Foley A; Cox B; Andrews D; Sachs DH; Sykes M
    Biol Blood Marrow Transplant; 2000; 6(3A):309-20. PubMed ID: 10905768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.
    Sehn LH; Alyea EP; Weller E; Canning C; Lee S; Ritz J; Antin JH; Soiffer RJ
    J Clin Oncol; 1999 Feb; 17(2):561-8. PubMed ID: 10080600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photochemical treatment of donor lymphocytes inhibited their ability to facilitate donor engraftment or increase donor chimerism after nonmyeloablative conditioning or establishment of mixed chimerism.
    Johnson BD; Taylor PA; Stankowski MC; Talib S; Hearst JE; Blazar BR
    Biol Blood Marrow Transplant; 2002; 8(11):581-7. PubMed ID: 12463476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ghrelin Protects the Thymic Epithelium From Conditioning-Regimen-Induced Damage and Promotes the Restoration of CD4+ T Cells in Mice After Bone Marrow Transplantation.
    Xu J; Zhu J; Tian X; Sun Q; Xu J; Huang Y; He Y; Huang Z; Wu B
    Transplantation; 2017 Sep; 101(9):e293-e300. PubMed ID: 28538498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of IL-22 on thymus recovery and its function in mice following allogeneic bone marrow transplantation].
    Zhao K; Zhao D; Yin L; Pan B; Xu K
    Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):822-5. PubMed ID: 25246251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
    Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
    Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT.
    Johnson BD; Konkol MC; Truitt RL
    Biol Blood Marrow Transplant; 2002; 8(10):525-35. PubMed ID: 12434947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion.
    Schattenberg A; Schaap N; Van De Wiel-Van Kemenade E; Bär B; Preijers F; Van Der Maazen R; Roovers E; De Witte T
    Leuk Lymphoma; 1999 Jan; 32(3-4):317-25. PubMed ID: 10037029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells.
    Blazar BR; Taylor PA; Boyer MW; Panoskaltsis-Mortari A; Allison JP; Vallera DA
    J Immunol; 1997 Oct; 159(7):3460-73. PubMed ID: 9317145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation.
    Kraus AB; Shaffer J; Toh HC; Preffer F; Dombkowski D; Saidman S; Colby C; George R; McAfee S; Sackstein R; Dey B; Spitzer TR; Sykes M
    Exp Hematol; 2003 Jul; 31(7):609-21. PubMed ID: 12842706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of allogeneic hematopoietic stem cell transplantation plus thymus transplantation on malignant tumors: comparison between fetal, newborn, and adult mice.
    Zhang Y; Hosaka N; Cui Y; Shi M; Ikehara S
    Stem Cells Dev; 2011 Apr; 20(4):599-607. PubMed ID: 20672991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordant xenogeneic neonatal thymic transplantation can induce donor-specific tolerance.
    Khan A; Sergio JJ; Zhao Y; Pearson DA; Sachs DH; Sykes M
    Transplantation; 1997 Jan; 63(1):124-31. PubMed ID: 9000673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor bone marrow-derived T cells inhibit GVHD induced by donor lymphocyte infusion in established mixed allogeneic hematopoietic chimeras.
    Wang H; Yang Y; Wang G; Wang S; Yeap BY; Sykes M; Yang YG
    PLoS One; 2012; 7(10):e47120. PubMed ID: 23077554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Sachs DH; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathymic tolerance induction: determination of tolerance to class II major histocompatibility complex antigens in maturing T lymphocytes by a bone marrow-derived non-lymphoid thymus cell.
    Zepp F; Cussler K; Mannhardt W; Schofer O; Schulte-Wissermann H
    Scand J Immunol; 1987 Dec; 26(6):589-601. PubMed ID: 3501157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of mixed lymphocyte reaction nonresponsiveness after chimeric thymus transplantation.
    Palathumpat V; Sobis H; Vandeputte M; Michielsen P; Waer M
    Transpl Int; 1990 Dec; 3(4):217-21. PubMed ID: 2150169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.